01 1Chemeca Drugs
01 1RIFAXIMIN
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2025-11-07
Pay. Date : 2025-09-25
DMF Number : 42611
Submission : 2025-09-19
Status : Active
Type : II
20
Chemeca Drugs Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is RIFAXIMIN, with a corresponding US DMF Number 42611.
Remarkably, this DMF maintains an Active status since its submission on September 19, 2025, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 07, 2025, and payment made on September 25, 2025, indicating their dedication to facilitating drug approvals, Categorized as Type II
